Human Cell Biology ELISA Kits 5
Human TDGF1 (Teratocarcinoma Derived Growth Factor 1) CLIA Kit (HUES00836)
- SKU:
- HUES00836
- Product Type:
- ELISA Kit
- ELISA Type:
- CLIA Kit
- Size:
- 96 Assays
- Sensitivity:
- 18.75pg/mL
- Range:
- 31.25-2000pg/mL
- ELISA Type:
- Sandwich
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cell Biology
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection method: | Chemiluminescence |
Detection range: | 31.25-2000 pg/mL |
Sensitivity: | 18.75 pg/mL |
Sample volume: | 100µL |
Sample type: | Serum, plasma and other biological fluids |
Repeatability: | CV < 15% |
Specificity: | This kit recognizes Human TDGF1 in samples. No significant cross-reactivity or interference between Human TDGF1 and analogues was observed. |
This kit uses Sandwich-CLIA as the method. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Human TDGF1. Standards or samples are added to the appropriate micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TDGF1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TDGF1, biotinylated detection antibody and Avidin-HRP conjugate will appear fluorescence. The Relative light unit (RLU) value is measured spectrophotometrically by the Chemiluminescence immunoassay analyzer. The RLU value is positively associated with the concentration of Human TDGF1. The concentration of Human TDGF1 in the samples can be calculated by comparing the RLU of the samples to the standard curve.
UniProt Protein Function: | TDGF1: Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm. Interacts with the activin type-1 receptor ACVR1B. Preferentially expressed in gastric and colorectal carcinomas than in their normal counterparts. Expressed in breast and lung. |
UniProt Protein Details: | Protein type:Membrane protein, GPI anchor; Membrane protein, peripheral; Motility/polarity/chemotaxis; Cell adhesion; Cell cycle regulation Chromosomal Location of Human Ortholog: 3p21. 31 Cellular Component: extrinsic to plasma membrane; Golgi apparatus; extracellular space; cell surface; perinuclear region of cytoplasm; apical plasma membrane; plasma membrane; nucleus; lipid raft Molecular Function:protein binding; growth factor activity; receptor binding Biological Process: activation of MAPK activity; somatic stem cell maintenance; heart development; regulation of signal transduction; gastrulation; Wnt receptor signaling pathway through beta-catenin; cardiac muscle cell differentiation; BMP signaling pathway; positive regulation of fibroblast proliferation; mammary gland development; determination of anterior/posterior axis, embryo; positive regulation of cell proliferation; vasculogenesis; positive regulation of cell-matrix adhesion; cell differentiation; epidermal growth factor receptor signaling pathway; in utero embryonic development; morphogenesis of a branching structure; embryonic development; peptidyl-serine phosphorylation; positive regulation of peptidyl-tyrosine phosphorylation; cell migration during sprouting angiogenesis; positive regulation of transcription from RNA polymerase II promoter; negative regulation of transforming growth factor beta receptor signaling pathway; negative regulation of apoptosis; positive regulation of cell migration |
NCBI Summary: | This gene encodes an epidermal growth factor-related protein that contains a cripto, FRL-1, and cryptic domain. The encoded protein is an extracellular, membrane-bound signaling protein that plays an essential role in embryonic development and tumor growth. Mutations in this gene are associated with forebrain defects. Pseudogenes of this gene are found on chromosomes 2, 3, 6, 8, 19 and X. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010] |
UniProt Code: | P13385 |
NCBI GenInfo Identifier: | 117473 |
NCBI Gene ID: | 6997 |
NCBI Accession: | P13385. 1 |
UniProt Secondary Accession: | P13385,Q8TCC1, |
UniProt Related Accession: | P13385 |
Molecular Weight: | 21,169 Da |
NCBI Full Name: | Teratocarcinoma-derived growth factor 1 |
NCBI Synonym Full Names: | teratocarcinoma-derived growth factor 1 |
NCBI Official Symbol: | TDGF1 |
NCBI Official Synonym Symbols: | CR; CRGF; CRIPTO |
NCBI Protein Information: | teratocarcinoma-derived growth factor 1 |
UniProt Protein Name: | Teratocarcinoma-derived growth factor 1 |
UniProt Synonym Protein Names: | Cripto-1 growth factor; CRGF; Epidermal growth factor-like cripto protein CR1 |
Protein Family: | Teratocarcinoma-derived growth factor |
UniProt Gene Name: | TDGF1 |
UniProt Entry Name: | TDGF1_HUMAN |
As the RLU values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (pg/mL) | RLU | Average | Corrected |
2000 | 53491 57951 | 55721 | 55693 |
1000 | 22983 24965 | 23974 | 23946 |
500 | 11407 10657 | 11032 | 11004 |
250 | 5281 5307 | 5294 | 5266 |
125 | 2803 2413 | 2608 | 2580 |
62.5 | 1373 1249 | 1311 | 1283 |
31.25 | 667 681 | 674 | 646 |
0 | 27 29 | 28 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human TDGF1 were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human TDGF1 were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 101.64 | 248.50 | 736.10 | 96.20 | 234.70 | 793.69 |
Standard deviation | 12.14 | 29.07 | 76.70 | 11.08 | 17.77 | 50.56 |
C V (%) | 11.94 | 11.70 | 10.42 | 11.52 | 7.57 | 6.37 |
Recovery
The recovery of Human TDGF1 spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 85-97 | 91 |
EDTA plasma (n=5) | 96-110 | 102 |
Cell culture media (n=5) | 91-103 | 96 |
Linearity
Samples were spiked with high concentrations of Human TDGF1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 93-106 | 88-98 | 93-107 |
Average (%) | 100 | 93 | 100 | |
1:4 | Range (%) | 94-108 | 86-100 | 97-110 |
Average (%) | 100 | 92 | 104 | |
1:8 | Range (%) | 88-103 | 103-118 | 88-101 |
Average (%) | 94 | 110 | 94 | |
1:16 | Range (%) | 93-107 | 89-102 | 99-115 |
Average (%) | 99 | 94 | 106 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro CLIA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent A | 1 vial, 5 mL | 4°C (shading light) |
Substrate Reagent B | 1 vial, 5 mL | 4°C (shading light) |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100µl of standard solutions into the standard wells.
- Add 100µl of Sample / Standard dilution buffer into the control (zero) well.
- Add 100µl of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids. ) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37°C.
- Aspirate the liquid from each well, do not wash. Immediately add 100µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37°C.
- Aspirate or decant the solution from the plate and add 350µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37°C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 100µL of Substrate mixture solution to each well. Cover with a new plate seal andincubate for no more than 5 min at 37°C. Protect the plate from light.
- Determine the RLU value of each well immediately.